118 days
12 hours
53 mins
XXVI Annual Congress

The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in
gene therapy, cell therapy and genetic vaccines by facilitating education, the exchange of
information and technology, and by serving as a professional adviser to stakeholder communities
and regulatory bodies in Europe.

Icon
UPDATE
 

REGISTER NOW
Registration & abstract submission for our 2018 Annual Congress IS NOW OPEN! 

The Gene & Cell Therapy Community Heatmap is a fully interactive and searchable map with information on the expertise of organisations working
on gene and cell therapy in Europe.  Academic research institutes (red), biotech and pharma companies (yellow) and non-profits and charities (green) are all included. You can add your own organisation through an online form (click the map to go to the full version).


 

Latest News

This week in gene and cell therapy - 15 June 2018

Read more

This week in gene and cell therapy - 8 June 2018

Read more

This week in gene and cell therapy - 1 June 2018

Read more

AFM- Téléthon call for projects on Bioproduction Breakthrough in Gene Therapy Technologies

Read more

This week in gene and cell therapy - 25 May 2018

Read more

This week in gene and cell therapy - 18 May 2018

Read more

This week in gene and cell therapy - 4 May 2018

Read more

This week in gene and cell therapy - 27 April 2018

Read more

This week in gene and cell therapy - 20 April 2018

Read more

This week in gene and cell therapy - 6 April 2018

Read more

Promising results of stem cell therapy for MS

Read more

This week in gene and cell therapy - 9 March 2018

Read more

This week in gene and cell therapy - 16 February 2018

Read more

This week in gene and cell therapy - 2 February 2018

Read more

This week in gene and cell therapy - 19 January 2018

Read more

This week in gene and cell therapy - 12 January 2018

Read more

This week in gene and cell therapy - 5 January 2018

Read more

2017 breakthroughs in medicine dominated by gene and cell therapy

Read more

FDA approved Luxturna, a gene therapy product for inherited blindness

Read more

BBC resource on gene and cell therapies, including interview with Robin Ali

Read more

This week in gene and cell therapy - 8 December 2017

Read more

2017 ESGCT DG-GT Congress Education Day video now online

Read more

This week in gene and cell therapy - 1 December 2017

Read more

This week in gene and cell therapy - 24 November 2017

Read more

This week in gene and cell therapy - 3 November 2017

Read more

This week in gene and cell therapy - 27 October 2017

Read more

New base editor extends machinery to correct single base pair mutations

Read more

First FDA approval for CAR-T cell therapy

Read more

First report of JCAR017 trial: CAR-T cell activity observed in the brain

Read more

Gene addition of micro-dystrophin improves Duchenne muscular dystrophy symptoms in dogs

Read more

Proof of concept for new strategy of genome editing to correct splice-site mutations

Read more

Step forward for precision medicine - personalised anti-cancer vaccine tested in patients

Read more

Genome editing used to treat Huntington's disease in mice

Read more

New developments in blood cell therapy

Read more

First clinical trial with in vivo genome editing

Read more

Phase I trial of gene therapy for age-related macular degeneration completed

Read more

ESGCT welcomes two Student Board Members

Read more

Feng Zhang Discusses CRISPR and Future of Gene Editing in Interview in Human Gene Therapy

Read more

New gene therapy success in a rare disease of the immune system: Wiskott-Aldrich syndrome

Read more

First stem-cell therapy recommended for approval in EU

Read more